PMV Pharmaceuticals, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for PMVP, updated each market day.
PMVP AI Sentiment
AI sees no strong directional signal for PMV Pharmaceuticals, Inc stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About PMV Pharmaceuticals, Inc
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Sector
Exchange
Market Cap
$76,261,030
Cap Tier
Employees
54
Headquarters
PRINCETON, NJ
Listed Since
Sept. 25, 2020
Website
PMVP Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PMVP Volatility
PMV Pharmaceuticals, Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
